Vaxart Inc (VXRT NASDAQ) stock market data APIs
$0.3918
-0.02(-5.1%)
as of November 18, 2025
Try our APIs with
free plan!
Vaxart Inc Financial Data Overview
Price chart is built with
Anychart
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
Prev. Close
0.3918
Open
0.3741
High
0.4129
Low
0.3693
52 wk Range
0.2606-0.98
Market Cap
93 935 K
Shares Outstanding
240 M
Revenue
80 724 K
EPS
-0.04
Beta
0.895
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Vaxart Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vaxart Inc data using free add-ons & libraries
Get Vaxart Inc Fundamental Data
Vaxart Inc Fundamental data includes:
- Net Revenue: 80 724 K
- EBITDA: -46 601 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.0667
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vaxart Inc News
New
Vaxart, Precigen among biotech gainers after Q3 results
[Close up image of wooden cubes with alphabet Q3 on office desk.] mohd izzuan Shares of oral vaccine developer Vaxart (OTC:VXRT [https://seekingalpha.com/symbol/VXRT]) and immunotherapy maker Precige...
Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts
Earnings Call Insights: Vaxart, Inc. (VXRT) Q3 2025 MANAGEMENT VIEW * CEO Steven Lo announced a major partnership with Dynavax, under which Vaxart could receive up to $700 million in license, regu...
Vaxart GAAP EPS of -$0.04 beats by $0.03, revenue of $72.4M beats by $32.3M
* Vaxart press release [https://seekingalpha.com/pr/20307313-vaxart-provides-business-update-and-reports-third-quarter-2025-financial-results] (OTC:VXRT [https://seekingalpha.com/symbol/VXRT]): Q3 G...
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results
Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
